跳至主要内容
临床试验/NCT03382613
NCT03382613终止不适用

Quantify Use of Anticoagulation to Improve Management of AF

Janssen Scientific Affairs, LLC61 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2017年12月29日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
2,000
试验地点
61
主要终点
Change in the Percentage of Patients Treated With OAC From Baseline to Final Collection Periods

研究概览

简要总结

The purpose of this study is to evaluate the impact of a hospital quality improvement (QI) program on the use of guideline-recommended oral anticoagulants (OAC) in hospitalized patients with atrial fibrillation (AF) at risk for ischemic stroke. Specifically, the study will determine whether the intervention, compared to Usual Care, will result in a greater increase in the proportion of patients with AF at risk for ischemic stroke who are appropriately treated with OAC.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Inpatient hospitalization
  • Primary or secondary discharge International Classification of Diseases (ICD)-9/10 diagnosis code for AF paroxysmal (I48.0), persistent (I48.1), chronic (I48.2), or unspecified (427.31, I48.91)
  • Proxied Congestive Heart failure (CHA2DS2-VASC) score greater than or equal to (>=) 2 using ICD-9 diagnosis scoring algorithm developed previously. The scoring algorithm will be expanded to include ICD-10 codes
  • Discharged to home, skilled nursing facility, inpatient rehabilitation, or nursing home

排除标准

  • Presence of artificial mechanical heart valve by ICD-9/10 diagnosis or procedure code during comorbid identification period or current hospitalization
  • Surgical procedure during hospitalization for open heart surgery, brain, or spine
  • Intravenous heparin given on the day of discharge without warfarin/oral anticoagulant (OAC), antiplatelets, and/or aspirin
  • History of left atrial appendage occlusion, including the Watchman device
  • Any in-hospital (current hospitalization) bleeding identified by ICD-9/10 diagnosis codes

结局指标

主要结局

Change in the Percentage of Patients Treated With OAC From Baseline to Final Collection Periods

时间窗: Baseline up to 20 months

The impact of a hospital quality improvement (QI) program on the use of guideline-recommended oral anticoagulants (OAC) in hospitalized patients with atrial fibrillation (AF) at risk for ischemic stroke will be evaluated by measuring change in the percentage of patients treated with OAC, from baseline to Final Collection Periods.

次要结局

  • Effect of Degree of Engagement in the QI Program(End of study (Month 20))
  • Percentage of Patients Readmitted to the Same Hospital(Up to 20 months)
  • Percentage of Patients who Received OAC by Hospital Characteristics Subgroups(End of study (Month 20))
  • Effect of Tools Components of the QI Program on the use of OAC(End of study (Month 20))

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (61)

Loading locations...

相似试验